Wataru Endo has given an update on his future at Liverpool, amidst reports linking him with a move away from the club ...

Mallinckrodt and Endo announced that their respective shareholders have provided the necessary shareholder approvals for the companies to combine in a stock and cash transaction that will create a ...

Wataru Endo has reiterated his desire to stay put at Liverpool this summer. The Japan international found himself limited to a bit-part role at Anfield last season following Arne Slot’s ...

Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, primarily operated ...

Mallinckrodt plc ("Mallinckrodt") and Endo, Inc. (OTCQX: NDOI) ("Endo") today announced the future executive team that will drive the creation of global, scaled, diversified therapeutics leaders ...

Endo Inc. approved more than $3.5 million in retention bonuses for key executives, and that figure could grow, as it works to finalize its merger with Mallinckrodt.

Four Lives Remain: Tatsuya Endo Before Spy x Family is a manga collection that offers insight into a now-famous creator's background.

EAST WHITELAND — Endo, a pharmaceutical company that has its global headquarters in Chester County, is being acquired by Ireland’s Mallinckrodt in a cash-and-stock deal valued at $6.7 billion.

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York Stock Exchange, the two drugmakers said Thursday.

Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...

Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the transaction.